The paper presents the results of clinical use ofglargin insulin (Lantus) in the work of the Moscow endocrinological service. It gives an assessment of the effectiveness, safety, and satisfaction with treatment for diabetes mellitus (DM). The data on a follow-up of patients receiving Lantus as basal insulin in real clinical practice are shown.
View Article and Find Full Text PDFVestn Rentgenol Radiol
March 1970